Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 5/2005

01-10-2005 | Review

Imaging in breast cancer: Magnetic resonance imaging

Authors: Constance D Lehman, Mitchell D Schnall

Published in: Breast Cancer Research | Issue 5/2005

Login to get access

Abstract

Over the past 5 years there has been a marked increase in the use of magnetic resonance imaging (MRI) of the breast. Multiple research studies have confirmed improved cancer detection, diagnosis, and evaluation of response to therapy with breast MRI compared with mammography and ultrasound. As this exciting new technology advances, focused work in optimal scan protocols, appropriate clinical applications, and image interpretation are needed. Both the potential benefits and harms need to be evaluated to guide optimal use of this imaging modality in select patient populations.
Appendix
Available only for authorised users
Literature
1.
Mansfield P, Morris P, Ordidge R, Coupland R, Bishop H, Blamey R: Carcinoma of the breast imaged by nuclear magnetic resonance (NMR). Br J Radiol. 1979, 52: 242-243.CrossRefPubMed
2.
Heywang S, Fenzl G, Hahn D, Krischke I, Edmaier M, Eiermann W, Bassermann R: MR imaging of the breast: comparison with mammography and ultrasound. J Comput Assist Tomogr. 1986, 10: 615-620.CrossRefPubMed
3.
Kaiser W, Zeitler E: MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology. 1989, 170: 681-686.CrossRefPubMed
4.
Harms SE, Flamig DP: MR imaging of the breast: technical approach and clinical experience. Radiographics. 1993, 13: 905-912.CrossRefPubMed
5.
Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH: Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology. 1999, 211: 101-110.CrossRefPubMed
6.
Kuhl CK, Schild HH: Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging. 2000, 12: 965-974. 10.1002/1522-2586(200012)12:6<965::AID-JMRI23>3.0.CO;2-1.CrossRefPubMed
7.
American College of Radiology: ACR BI-RADS® – MRI. ACR Breast Imaging Reporting and Data System. Breast Imaging Atlas. 2003, Reston, VA: American College of Radiology
8.
Bluemke D, Gatsonis C, Chen M, DeAngelis G, DeBruhl N, Harms S, Heywang-Kobrunner S, Hylton N, Kuhl C, Lehman C, et al: Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004, 292: 2735-2742. 10.1001/jama.292.22.2735.CrossRefPubMed
9.
Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV: MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993, 187: 493-501.CrossRefPubMed
10.
Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, Callans LS, Buzby GP, Rosato EF, Fraker DL, et al: Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003, 98: 468-473. 10.1002/cncr.11490.CrossRefPubMed
11.
Tan JEOS, Schnall MD, Schultz DJ, Solin LJ: Role of magnetic resonance imaging and magnetic resonance imaging – guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol. 1999, 22: 414-418. 10.1097/00000421-199908000-00020.CrossRefPubMed
12.
Schnall MD, Blume J, Bluemke D, Smazal S, Deangelis G, Harms S, Kuhl C, Hylton N, Gatsonis C, International Breast MRI Consortium: MRI detection of multi focal breast carcinoma: report from the International Breast MRI Consortium. J Clin Oncol. 2004, 22 (Suppl): 14S-
13.
Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, et al: Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004, 101: 1977-1986. 10.1002/cncr.20617.CrossRefPubMed
14.
Lehman CD, Blume JD, Thickman D, Bluemke DA, Pisano E, Kuhl K, Julian T, Hylton N, Weatherall P, O'Loughlin M, et al: The added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005,
15.
Orel S, Weinstein S, Schnall M, Reynolds C, Schuchter L, Fraker D, Solin L: Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology. 1999, 212: 543-549.CrossRefPubMed
16.
Gilles R, Guinebretiere JM, Toussaint C, Spielman M, Rietjens M, Petit JY, Contesso G, Masselot J, Vanel D: Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology. 1994, 191: 633-638.CrossRefPubMed
17.
Rosen EL, Blackwell KL, Baker JA, Soo MS, Bentley RC, Yu D, Samulski TV, Dewhirst MW: Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol. 2003, 181: 1275-1282.CrossRefPubMed
18.
Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM: Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol. 2002, 179: 1193-1199.CrossRefPubMed
19.
Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A, Maringa M, Pfeifer U, Krebs D, Schild HH: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology. 2000, 215: 267-279.CrossRefPubMed
20.
Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004, 292: 1317-1325. 10.1001/jama.292.11.1317.CrossRefPubMed
21.
Podo F, Sardanelli F, Canese R, D'Agnolo G, Natali PG, Crecco M, Grandinetti ML, Musumeci R, Trecate G, Bergonzi S, et al: The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res. 2002, 21 (Suppl 3): 115-124.PubMed
22.
Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M: First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat. 2000, 63: 53-60. 10.1023/A:1006480106487.CrossRefPubMed
23.
Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, Dershaw DD: MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol. 2003, 181: 619-626.CrossRefPubMed
24.
Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, et al: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004, 351: 427-437. 10.1056/NEJMoa031759.CrossRefPubMed
25.
Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M: Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005, 103: 1898-1905. 10.1002/cncr.20971.CrossRefPubMed
26.
Bolan PJ, Nelson MT, Yee D, Garwood M: Imaging in breast cancer: magnetic resonance spectroscopy. Breast Cancer Res. 2005, 7: 149-152. 10.1186/bcr1202.CrossRefPubMedPubMedCentral
Metadata
Title
Imaging in breast cancer: Magnetic resonance imaging
Authors
Constance D Lehman
Mitchell D Schnall
Publication date
01-10-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 5/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1309

Other articles of this Issue 5/2005

Breast Cancer Research 5/2005 Go to the issue

Meeting report

The Fourth International Symposium on the Intraductal Approach to Breast Cancer, Santa Barbara, California, 10–13 March 2005

Research article

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines

Research article

Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells

Commentary

A mathematical model for the effect of a false-negative sentinel node biopsy on breast cancer mortality: a tool for everyday use

Research article

Somatic mutation and gain of copy number of PIK3CA in human breast cancer

Research article

Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits